Compare CRDO & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRDO | GEHC |
|---|---|---|
| Founded | 2008 | 1892 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Computer Software: Prepackaged Software |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.2B | 33.1B |
| IPO Year | 2022 | N/A |
| Metric | CRDO | GEHC |
|---|---|---|
| Price | $148.52 | $83.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 9 |
| Target Price | ★ $179.91 | $86.67 |
| AVG Volume (30 Days) | ★ 7.4M | 3.5M |
| Earning Date | 12-01-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 0.17% |
| EPS Growth | N/A | ★ 32.35 |
| EPS | 1.11 | ★ 4.83 |
| Revenue | $796,128,000.00 | ★ $20,246,000,000.00 |
| Revenue This Year | $127.02 | $6.33 |
| Revenue Next Year | $28.18 | $4.34 |
| P/E Ratio | $134.88 | ★ $17.38 |
| Revenue Growth | ★ 224.17 | 3.51 |
| 52 Week Low | $29.09 | $57.65 |
| 52 Week High | $213.80 | $94.80 |
| Indicator | CRDO | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 46.26 | 58.24 |
| Support Level | $132.76 | $81.74 |
| Resistance Level | $156.09 | $84.18 |
| Average True Range (ATR) | 9.87 | 1.90 |
| MACD | -1.88 | -0.25 |
| Stochastic Oscillator | 28.08 | 42.89 |
Credo Technology Group Holding Ltd delivers high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. It provides secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. It has a geographic presence in Hong Kong, the United States, Mainland China, Taiwan, and the Rest of the World.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).